Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial

Summary

For many patients peritoneal dialysis (PD) is the preferred form of dialysis to treat kidney disease as it provides greater flexibility and the ability to dialyse at home. However, PD use in Australia has been decreasing over the last 10 years. A big reason for this drop is the risk of infection. The best way to prevent PD related infections is to make sure that patients have good training in PD techniques. The researchers of this study have developed TEACH-PD, a new education package for training both PD nurses and PD patients.

The aim of this study is to find out whether TEACH-PD training reduces the number of PD related infections.

Conditions

• Kidney Disease, Chronic
• Peritoneal Dialysis Catheter-Associated Peritonitis
• Peritoneal Dialysis Catheter Exit Site Infection
• Peritoneal Dialysis Catheter Tunnel Infection

Interventions

BEHAVIORAL

TEACH-PD Training Curriculum

The TEACH-PD training modules have been developed by a core group of renal nurses from the HOME Network in conjunction with senior medical clinicians from the Australasian Kidney Trials Network, eLearning curriculum developers, consumer representatives, and education experts, in line with the International Society for Peritoneal Dialysis guidelines, utilizing modern adult learning principles and best practice eLearning techniques.

BEHAVIORAL

Current standard PD training

Current PD training materials and plan

Sponsors & Collaborators

• The HOME Network

  collaborator UNKNOWN

• Australia and New Zealand Dialysis and Transplant Registry

  collaborator UNKNOWN

• New Zealand Peritoneal Dialysis Registry

  collaborator UNKNOWN

• The University of Queensland

  lead OTHER

Principal Investigators

• Neil C Boudville, Prof · University of Western Australia & Sir Charles Gairdner Hospital

• Josephine S Chow, Prof · South Western Sydney Local Health District

• Yeoungjee Cho, PhD · Queensland Health/Princess Alexandra Hospital

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2019-07-22

Primary Completion

2025-03-31

Completion

2025-04-30

Countries

• Australia
• New Zealand

Study Locations